Bao SQ - Search Results

1

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.

Zhang Q, Yuan XF, Lu Y, Li ZZ, Bao SQ, Zhang XL, Yang YY, Fan DM, Zhang YZ, Wu CX, Guo HX, Zhang YJ, Ye Z, Xiong DS. Zhang Q, et al. Among authors: bao sq. Int J Cancer. 2017 Oct 1;141(7):1445-1457. doi: 10.1002/ijc.30846. Epub 2017 Jul 7. Int J Cancer. 2017. PMID: 28643325

2

A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity.

Jiang L, Yang M, Zhang X, Bao S, Ma L, Fan D, Zhou Y, Xiong D, Zhen Y. Jiang L, et al. J Drug Target. 2016;24(1):47-57. doi: 10.3109/1061186X.2015.1055568. Epub 2015 Jul 23. J Drug Target. 2016. PMID: 26204323

3

Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.

Yuan X, Zhang Q, Li Z, Zhang X, Bao S, Fan D, Ru Y, Dong S, Zhang Y, Zhang Y, Ye Z, Xiong D. Yuan X, et al. Cancer Lett. 2016 Oct 10;381(1):85-95. doi: 10.1016/j.canlet.2016.07.019. Epub 2016 Jul 20. Cancer Lett. 2016. PMID: 27450327

4

An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma.

Fan D, Jiang L, Song Y, Bao S, Yang Y, Yuan X, Zhen Y, Yang M, Xiong D. Fan D, et al. Front Oncol. 2019 Sep 4;9:861. doi: 10.3389/fonc.2019.00861. eCollection 2019. Front Oncol. 2019. PMID: 31555598 Free PMC article.

5

Ovatodiolide inhibited hepatocellular carcinoma stemness through SP1/MTDH/STAT3 signaling pathway.

Chen T, Wang Q, Liu C, Zhang F, Bai Y, Jiao Y, Wang M, Bao S, Liu B, Shao M, Ma S, Ding Y. Chen T, et al. Chem Biol Interact. 2024 Sep 1;400:111161. doi: 10.1016/j.cbi.2024.111161. Epub 2024 Jul 23. Chem Biol Interact. 2024. PMID: 39053793

6

Design, Synthesis and Biological Evaluation of Jahanyne Analogs as Cell Cycle Arrest Inducers.

Ye B, Gong J, Li Q, Bao S, Zhang X, Chen J, Meng Q, Chen B, Jiang P, Wang L, Chen Y. Ye B, et al. Mar Drugs. 2020 Mar 23;18(3):176. doi: 10.3390/md18030176. Mar Drugs. 2020. PMID: 32210159 Free PMC article.

7

A Two-Phase Approach to Fusicoccane Synthesis To Uncover a Compound That Reduces Tumourigenesis in Pancreatic Cancer Cells.

Chen B, Wu Q, Xu D, Zhang X, Ding Y, Bao S, Zhang X, Wang L, Chen Y. Chen B, et al. Angew Chem Int Ed Engl. 2022 May 2;61(19):e202117476. doi: 10.1002/anie.202117476. Epub 2022 Feb 25. Angew Chem Int Ed Engl. 2022. PMID: 35166433

8

Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile.

Xiang J , Zhang X , Wang D , Li J , Li Q , Wang Q , Ding Y , Chen T , Sun Y , Bao S , Chen J , Li D , Wang L , Chen Y . Xiang J , et al. Chem Commun (Camb). 2020 Sep 25;56(75):11018-11021. doi: 10.1039/c9cc07573a. Epub 2020 Aug 28. Chem Commun (Camb). 2020. PMID: 32856652

9

Synthesis and Anti-Inflammatory Activity of Ferulic Acid-Sesquiterpene Lactone Hybrids.

Duan X, Liu N, Lv K, Wang J, Li M, Zhang Y, Huo X, Bao S, Shen Z, Zhang X. Duan X, et al. Molecules. 2024 Feb 21;29(5):936. doi: 10.3390/molecules29050936. Molecules. 2024. PMID: 38474447 Free PMC article.

10

ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF-κB activation.

Jin XH, Jia YS, Shi YH, Li QY, Bao SQ, Lu WP, Tong ZS. Jin XH, et al. Among authors: bao sq. J Cell Biochem. 2019 Feb;120(2):1386-1397. doi: 10.1002/jcb.27146. Epub 2018 Nov 18. J Cell Biochem. 2019. PMID: 30450651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters